splenic, 11 i.m., 12 subcutaneous 13 and i.o. routes in animals.
/l. Details regarding patient care have been times used in critically ill children. 3 In the early era of bone reported. 18 Total parenteral nutrition (TPN) was defined as marrow transplantation (BMT), sporadic attempts were the administration of at least 2.5 l of a combination of intramade to administer bone marrow orally 4 as well as intralipid, amino acids and glucose (Kabimix basal, Pharmacia muscularly (i.m.), 5 intra-arterially 6 and i.o. 1, 7, 8 in humans and Upjohn, Stockholm, Sweden). and by intracardiac, intra-arterial, 9 intraperitoneal, 10 intraThe diagnoses were AML (n = 17), ALL (n = 1), CML (n = 14), lymphoma (n = 3), IgA myeloma (n = 1), CLL (n = 1) and metachromatic leukodystrophy (MLD, n = 1).
Correspondence: Dr H Hägglund, Dept of Transplantation Surgery, B56, There were no differences in patients' and donors' characHuddinge Hospital, S-141 86 Huddinge, Sweden Received 15 May 1997; accepted 28 September 1997 teristics between the three groups ( Table 1) . Early leukaemia = 1st remission of acute leukaemia or chronic phase of chronic myeloid leukaemia; more advanced = all other stages.
All patients received prophylaxis with cyclosporin A approved by the Isotope Committee at Huddinge Hospital and all patients had given their informed consent. The same (CsA) and methotrexate (MTX). 19 Patients with one antigen mismatch or non-malignant disorders received a higher isotope but in two different radiopharmaceuticals was used due to changed routines in the Department of Nuclear dose of CsA, as previously described.
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Medicine. The radiopharmaceuticals used were:
Complications
(1) Techneticum (Tc-99m) human serum albumin colloid, Solco Nanocoll (Nanocoll), from Solco Nuclear, Basel, Bacteraemia was defined as at least one positive blood culture related to a febrile episode (у38.5°C) during the first Switzerland. The labelling yield is guaranteed more than 95%. Nanocoll is phagocytised by the macromonth after BMT.
The diagnoses of acute and chronic GVHD were based phages in the reticulo-endothelial system (RES), which is located mainly in the liver, spleen and bone marrow on clinical signs. GVHD was graded from 0 to IV, using the criteria of Glucksberg et al. 21 Chronic GVHD was (2) Tc-99m labelled antigranulocyte monoclonal mouse antibody, BW 250/183, Scintimun Granulozyt (Mab), defined as limited or extensive.
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Mucositis was graded as 0-1 (normal or erythema) and from Behringwerke AG, Marburg, Germany. Mab cross-reacts with the non-specific cross-reacting anti-2-3 (erythema with solitary or confluent ulcers). 23 gen (NCA 95) on the membrane of granulocytes in the blood and on mature granulopoietic cells in the bone I.o. infusion marrow. The patients were given vancocin or cloxacillin 1 g i.v. and 5 mg morphine hydrochloride before infusion. Two bone Patients Nos 2 and 3 were imaged with Nanocoll and patients Nos 1, 4 and 5 with Mab. The radiopharmaceutmarrow aspiration needles (Adolfo 1.8 × 50 mm; Unimed, Lausanne, Switzerland) were inserted into each side of the icals were prepared according to the manufacturer's instructions. Nanocoll was administered i.v. to patients Nos 2 and posterior iliac crests under sterile conditions and under local anaesthesia in the patient's room. The infusion was 3, who were examined 19 and 20 days after transplantation. Mab was administered i.v. to the control patient (No. 1). given with or without overpressure, using a 50 cc syringe.
For the two patients who were imaged during bone marrow transplantation, Mab was first prepared according to the Bone marrow scintigraphy manufacturers's instructions. Thereafter, the prepared radiopharmaceutical was added to a vial with 5 ml of the Five patients were examined with bone marrow scintigraphy. The diagnoses are given in Table 2 . Patient No. 4, donated bone marrow and was administered immediately at the Department of Nuclear Medicine, by an i.o. aspirexamined during the i.v. transfusion, was in a clinically worse condition than the other patients. The study was ation needle in the posterior iliac crest to one patient (No. The control patient was scintigraphed after total body irradiation but before transplantation. Nanocoll = Solco Nanocoll, from Solco Nuclear, Basel, Switzerland; Mab = Scintimun Granulozyt, from Behringwerke AG, Marburg, Germany. The probabilities of developing bacteraemia were 0% in the Due to logistic difficulties, the recordings were perfori.o. group and 30% in the i.v. group (NS) ( Table 3) . Howmed with two different cameras. One was an analogue ever, compared to both i.o. groups, bacteraemia was siggamma-camera (General Electric Maxi Camera; Copennificantly increased in the i.v. group (P Ͻ 0.01). hagen, Denmark) with a general all-purpose collimator and
The probabilities of mucositis grades 2-3 were similar. a crystal with a diameter of 60 cm and a thickness of 12.7
The probabilities of developing acute and chronic GVHD mm. Anterior and posterior static images were taken of were the same in the i.o. and i.v. groups. I.v. antibiotics three patients (Nos 2, 3 and 4). The other was a digital tended to be commoner and TPN was given more often to camera (Siemens Diacam; Erlangen, Germany) with a lowthe i.v. group (Table 3) .
Both patients (Nos 4 and 5) examined during the transthe radiopharmaceutical was injected. Whole body recfusion had activity of the same intensity in the heart and ordings were performed immediately thereafter and after 1 large vessels immediately after the transfusion. No differh. Since no further change in distribution was expected for ence was found between the time when the radiolabelled the patients after transplantation, no later recordings were bone marrow spread in the skeleton in patients examined performed for patients Nos 2 and 3. For patients Nos 4 during transfusion by the i.o. and i.v. route. The i.o. transand 5, who received the transplant during the scintigraphic planted patient (No. 5) examined during the transfusion had examination, whole body recordings were also performed a high focal activity at the transfusion site at all recordings 3 h and 24 h after the administration of the labelled trans-(up to 24 h after transfusion). At the recordings at 1 h and plant. The control patient (No. 1) was imaged 3.5 h after later after injection, activity in the skull and the axial skelthe injection of the radiopharmaceutical (Table 2) ; the total eton were normal in all patients. Patients Nos 1, 2, 3 and body irradiation time and the time for transplantation did 4 showed peripheral bone marrow expansion, ie red bone not permit any further recordings. The scintigraphs were marrow was present beyond the normal proximal one third presented on hard-copy films and evaluated by two experiof the humeri and femora (Table 4) . enced radiologists.
Outcome

Statistical analysis
TRM, relapse, survival and LFS did not differ significantly between patients given i.o. or i.v. marrow (Table 3 ). The study was analysed on 15 January 1997. The median follow-up time was 33.5 (range 22.5-51) months. Bacteraemia, GVHD, TRM, relapse, LFS, etc, were analysed by the life-table method with the log-rank (Mantel-Haenzel) Discussion test. 24 For analysis of day of engraftment, etc, the Wilcoxon rank sum test was used.
In the early days of bone marrow transplantation, almost all sites for injection of bone marrow were investigated. During the 1930s and the 1940s, some case reports about i.o. infusion of human bone marrow were published. 1, 7, 8 In Results rats, it was found that i.o. injections of allogeneic bone marrow were just as effective as i.v. administration. 14 The marrow infusion procedure itself has changed little since I.o. infusion its inception in the 1960s, using only the i.v. route. 15 I.o. infusion of allogeneic bone marrow has not, to our knowAmong the nine i.o. randomized patients, eight received the ledge, been investigated in a prospective randomized whole bone marrow volume as an i.o. infusion and one fashion. The aim of this study was to transplant the stem patient had half the volume as an i.v. infusion, because of cells directly into the bone marrow stroma in the hope of severe pain during the i.o. infusion. This technique was accelerating haematopoietic recovery. It has been shown otherwise well tolerated, although almost all the patients that substances injected into the bone marrow are absorbed complained of some discomfort.
almost immediately into the central circulation in animals and humans. 25 The scintigraphic investigation in our patients demonstrates that the transfused bone marrow Engraftment and transfusions reaches the same sites and has the same engraftment time after the i.o. route as after the i.v. route. With bone marrow Engraftment classified as time to reach PMN Ͼ0.5 × 10 9 and platelets Ͼ30 × 10 9 /l were similar between groups. The scintigraphy we found activity in the bone marrow after total body irradiation, probably due to the persistence of need for transfusions was also similar. Two male patients, aged 45 and 43 years, given i.v. marrow were treated with mature granulocytes. We also found that the time for the transfused marrow to reach the heart and large vessels is granulocyte infusions because of high fever and bacteraemia not responding to antibiotics. the same using the i.o. and the i.v. routes. Some of the In this study, time-to-engraftment (PMN Ͼ0.5 × 10 9 /l) The incidences of acute and chronic GVHD, TRM, LFS and PS were about the same in patients receiving bone marafter allogeneic bone marrow transplantation was the same in the i.v. + i.o., i.o.and i.v. groups. However, patients row i.v. + i.o., i.o. or i.v. The disadvantages of the i.o. route are that it is invasive, receiving bone marrow via the i.o. route (both groups) had a lower incidence of bacteraemia during the first month it carries a risk of local infection and it causes some discomfort to the patient. Moreover, at least two persons are after BMT than did patients grafted via the i.v. route. This finding must be interpreted with caution because of the needed to perform it. The i.v. route is certainly simpler to use. small series. Due to the risk of osteomyelitis, reported to be 0.6% in more than 4000 i.o. infusions, all i.o. transplanted
We conclude that allogeneic bone marrow transplantation can safely be performed by i.o. infusion. However, patients were given a single dose of antibiotics prior to infusion. 26 It seems unlikely that this explains the differthis study supports the current clinical practice of i.v. infusion of haematopoietic stem cells. ence in bacteraemia in the two groups. Three additional patients received bone marrow via the i.o. route when the study ended. Two of these patients developed bacteraemia. Significantly fewer days on TPN and a tendency to fewer Acknowledgements days on antibiotics in the i.o. group correlated with the lower incidence of infections. Therefore, simple chance may also facilitate engraftment. [29] [30] [31] Therefore, these two methotrexate. A randomized trial in adult leukemic marrow
